findmyKOL
Clinical trialNCT00056628CompletedPhase 3Interventional

COGNIShunt® System for Alzheimer's Disease

SponsorEunoeEnrollment250Alzheimer Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Dawn McGuire, MD, Chief Scientific Officer

    Eunoe, Inc. 643 Bair Island Road, Redwood City, CA 94063

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2001
Primary completion
Completion
31 Oct 2004
Last update posted
12 Sept 2006
Registered enrollment
250
Registry id
NCT00056628

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.